161 related articles for article (PubMed ID: 37905340)
1. RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1/PDH axis.
Liu C; Shi J; Jiang Z; Jiang S; Wu Y; Peng D; Tang J; Guo L
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):44-53. PubMed ID: 37905340
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC00467 drives hepatocellular carcinoma progression via inhibiting NR4A3.
Wang H; Guo Q; Nampoukime KB; Yang P; Ma K
J Cell Mol Med; 2020 Apr; 24(7):3822-3836. PubMed ID: 32125766
[TBL] [Abstract][Full Text] [Related]
3. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
[TBL] [Abstract][Full Text] [Related]
4. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway.
Pan W; Li W; Zhao J; Huang Z; Zhao J; Chen S; Wang C; Xue Y; Huang F; Fang Q; Wang J; Brand D; Zheng SG
Mol Oncol; 2019 Oct; 13(10):2246-2258. PubMed ID: 31368655
[TBL] [Abstract][Full Text] [Related]
5. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1.
Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X
Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748
[TBL] [Abstract][Full Text] [Related]
6. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
[TBL] [Abstract][Full Text] [Related]
7. Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma.
Wang RY; Yang JL; Xu N; Xu J; Yang SH; Liang DM; Li JZ; Zhu H
World J Gastroenterol; 2024 Feb; 30(8):919-942. PubMed ID: 38516243
[TBL] [Abstract][Full Text] [Related]
8. Tumor Promoting Effect of Long Non-Coding RNA RP11-556E13.1 and its Clinical Significance in Hepatocellular Carcinoma.
Li J; Qiu X; Liu Z; Wang J; Wei Q; Zheng S; Xu X; Wang K
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345971
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long noncoding RNA AC245100.4 inhibits the tumorigenesis of prostate cancer cells via the STAT3/
Liu C; Lin P; Zhao J; Xie H; Li R; Yang X; Wang N; Jia H; Jiang S; Zhang K; Yu X
Epigenomics; 2021 Oct; 13(20):1591-1605. PubMed ID: 34657447
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk of LncRNA HOTAIR and SP1-mediated repression of PDK1 contributes to β-Elemene-inhibited proliferation of hepatocellular carcinoma cells.
Wu J; Tang X; Shi Y; Ma C; Zhang H; Zhang J; Lu Y; Wei J; Li L; Han L
J Ethnopharmacol; 2022 Jan; 283():114456. PubMed ID: 34333105
[TBL] [Abstract][Full Text] [Related]
11. RP11-81H3.2 Acts as an Oncogene via microRNA-490-3p Inhibition and Consequential Tankyrase 2 Up-Regulation in Hepatocellular Carcinoma.
Chen W; Li K; Zhu K; Yan R; Cai QC; Li WH; Dang CX
Dig Dis Sci; 2020 Oct; 65(10):2949-2958. PubMed ID: 31858324
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA RP11-909N17.2 promotes proliferation, invasion, and migration of hepatocellular carcinoma by regulating microRNA-767-3p.
Liu Q; Dai SJ; Dong L; Li H
Biochem Cell Biol; 2020 Dec; 98(6):709-718. PubMed ID: 33210543
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3.
Zhang M; Wu J; Zhong W; Zhao Z; Liu Z
Arch Biochem Biophys; 2018 Dec; 660():53-63. PubMed ID: 30227111
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis.
Fang QL; Zhou JY; Xiong Y; Xie CR; Wang FQ; Li YT; Yin ZY; Luo GH
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32100822
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis.
Wei F; Yang L; Jiang D; Pan M; Tang G; Huang M; Zhang J
Cancer Med; 2020 Apr; 9(7):2480-2490. PubMed ID: 32022476
[TBL] [Abstract][Full Text] [Related]
16. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway.
Li J; Xia T; Cao J; He D; Chen Z; Liang B; Song J
Aging (Albany NY); 2020 Jul; 12(14):14918-14932. PubMed ID: 32687483
[TBL] [Abstract][Full Text] [Related]
17. H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.
Xie N; Zhang R; Bi Z; Ren W; You K; Hu H; Xu Y; Yao H
Cell Oncol (Dordr); 2023 Apr; 46(2):375-390. PubMed ID: 36576700
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced in Hepatocellular Carcinoma.
Xu F; Li CH; Wong CH; Chen GG; Lai PBS; Shao S; Chan SL; Chen Y
Cancer Res; 2019 Apr; 79(7):1305-1317. PubMed ID: 30718359
[TBL] [Abstract][Full Text] [Related]
19. LncRNA RP11-620J15.3 promotes HCC cell proliferation and metastasis by targeting miR-326/GPI to enhance glycolysis.
Liu C; Xu K; Liu J; He C; Liu P; Fu Q; Zhang H; Qin T
Biol Direct; 2023 Apr; 18(1):15. PubMed ID: 37020316
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of pyruvate dehydrogenase kinase‑1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming.
Xu H; He Y; Ma J; Zhao Y; Liu Y; Sun L; Su J
Int J Oncol; 2020 Sep; 57(3):733-742. PubMed ID: 32705170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
